Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
Small Cap
LIACF
GBTC
From
Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
Tickers
GSK
MRK
RHHBY
SGEN
Tags
General
News
SGEN
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
TEVA
FRLN
DCPH
From
Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
MRK
ARKG
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
IBB
VALN
ABMD
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHVF
Health Care
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
General
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
General
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
MRK
CTLT
Trading Ideas
From
Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
General
Diabetic Macular Edema
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
RHHBF
Benzinga
From
Benzinga
These OTC Securities Had the Most Trading Activity in December
January 25, 2022
Tickers
ADDYY
AKZOY
BNPQY
CYDVF
Tags
General
News
NGLOY
From
Benzinga
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
Tickers
ABBV
ARNA
BIIB
JPM
Tags
VRTX
BIIB
PFE
From
Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
Tickers
AZN
BGNE
JPM
LPTX
Tags
BGNE
Market News
JPM
From
Motley Fool
Where Will Biogen Be in 5 Years?
January 15, 2022
Tickers
BIIB
NVS
RHHBY
SAGE
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
Tickers
BIIB
LLY
RHHBY
Tags
BIIB
RHHBY
LLY
From
MarketWatch
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Biotech
FDA
RHHBY
From
Benzinga
Why Shares of ImmunoGen Jumped 20.3% in December
January 03, 2022
Tickers
IMGN
RHHBY
Tags
Market News
Recent Press Releases
RHHBY
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Tickers
ALNY
ETON
IBB
NVS
Tags
NVS
Benzinga
ALNY
From
Benzinga
Why Lineage Cell Therapeutics Zoomed Higher Today
December 20, 2021
Tickers
LCTX
RHHBY
Tags
Recent Press Releases
LCTX
Market News
From
Motley Fool
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
December 20, 2021
Tickers
LCTX
RHHBF
RHHBY
RHHVF
Tags
Small Cap
Contracts
RHHVF
From
Benzinga
These OTC Securities Had the Most Trading Activity in November
December 16, 2021
Tickers
ADDYY
AYRWF
BNPQY
ETHE
Tags
ETHE
Penny Stocks
NGLOY
From
Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
Tickers
ASRT
ATRS
BIIB
CALT
Tags
RHHBY
FDA
Biotech
From
Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Buybacks
General
News
From
Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
AVIR
Briefs
Phase 2 Trial
From
Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
December 14, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
ASH21
Biotech
From
Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Tickers
APTO
ATRA
AZN
BLU
Tags
SNSE
Small Cap
Biotech
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Benzinga
Biotech
From
Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
Tickers
ABBV
ALLO
ARGX
AZN
Tags
RETA
IBB
Top Stories
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
breast cancer
Benzinga
Biotech
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.